Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Methods for Cardiac Fibroblast Generation from iPSCs: Updates and Characterization

ABSTRACT: Methods for Cardiac Fibroblast Generation from iPSCs: Updates and Characterization

PROVIDER: PRJNA704402 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13772300_1.fastq.gz	Fastqsanger.gz
	SRR13772300_2.fastq.gz	Fastqsanger.gz
	SRR13772301_1.fastq.gz	Fastqsanger.gz
	SRR13772301_2.fastq.gz	Fastqsanger.gz
	SRR13772302_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 20

Similar Datasets

Methods for Cardiac Fibroblast Generation from iPSCs: Updates and Characterization

Project description:Since the initial isolation of human embryonic stem cells and subsequent discovery of reprogramming methods for somatic cells, thousands of protocols have been developed to create each of the hundreds of cell types found in vivo with significant focus on disease-prone systems, e.g. cardiovascular. Robust protocols exist for many of these cell types, save cardiac fibroblasts (CF). Very recently, several competing methods have been developed to generate these cells through a developmentally conserved epicardial pathway. Such methods generate epicardial cells, but here we report that prolonged exposure to growth factors such as bFGF induces a more native morphology and similar chromatin architecture to primary CFs. Media conditions for growth and assays are provided, as well as suggestions for seeding densities and timepoints for protein harvest of extracellular matrix. We demonstrate marker expression and matrix competency of resultant cells as shown next to primary human cardiac fibroblasts. These methods provide additional guidance to the original protocol and result in an increasingly stable phenotype

2021-12-01 | GSE167368 | GEO

Improved epicardial cardiac fibroblast generation from iPSCs.

Project description: Not available

| S-EPMC9048147 | biostudies-literature

TEAD1 in cardiac fibroblast activation

Project description:TEAD1 in cardiac fibroblast activation

| PRJNA1064074 | ENA

Chromosomal status of GM00285 and GM05563 fibroblast and iPSCs

Project description:We generated induced pluripotent stem cells (iPSCs) from ring chromosome patients' cells. To examine chromosomal status in these iPSCs, we performed SNP microarray analysis using Agilent Sureprint G3 Human CGH + SNP 4x180k microarray platform. SNP analysis of fibroblast of GM00285 and GM05563 and iPSCs of GM00285 clone 1, GM00285 clone 3, GM05563 clone 1

2013-11-26 | E-GEOD-52585 | biostudies-arrayexpress

Nos3-/- iPSCs model concordant signatures of in utero cardiac pathogenesis [iPSCs]

Project description:Through genome-wide transcriptional comparisons, this study interrogates the capacity of iPSCs to accurately model pathogenic signatures of structural cardiac defects. Herein, we studied the molecular etiology of structural cardiac defects in Nos3-/- mice via transcriptional analysis of stage-matched embryonic and iPSC-derived tissues. In vitro comparisons of differentiated embryoid bodies were calibrated to in utero benchmarks of health and disease. Integrated systems biology analysis of WT and Nos3-/- transcriptional profiles revealed 50% concordant expression patterns between in utero embryonic and ex vivo iPSC-derived tissue. In particular, up-regulation of glucose metabolism (p-value = 3.95x10-12) and down-regulation of fatty acid metabolism (p-value = 6.71x10-12) highlight a bioenergetic signature of early Nos3 deficiency during cardiogenesis that can be recapitulated in iPSC-derived tissues. The in vitro concordance of early Nos3-/- disease signatures supports the utility of iPSCs as a cell-autonomous model of structural heart defects. Moreover, this study supports the use of iPSCs as a platform to pinpoint initial stages of cardiac pathogenesis.

2015-09-27 | GSE69316 | GEO

Expression data of the iPSCs derived from foreskin fibroblast cells of normal person and KS patient

Project description:Klinefelter’s Syndrome (KS) is one of the common chromosome aneuploidy diseases in males with unexplained physiological mechanism. iPSCs, are similar to ESCs in terms of indefinitive self-renewal and pluripotency, provided an alternative choice for modeling disease to facilitate the disease research in vitro. We used microarray to detect the global reprogramming of KS and normal fibroblast cells to iPSCs. Also we used microarray to explore the possible molecular varieties between KS patient and normal person in the early development. Fibroblast cells from both normal person and KS patient were reprogrammed into iPSCs by ectopic expression of OCT4, SOX2, KLF4 and C-MYC. The expression profiles of normal and KS fibroblast cells, a line of normal iPSCs and two lines of KS iPSCs as well as a line of human ESCs were detected.

2012-04-13 | E-GEOD-37258 | biostudies-arrayexpress

Enhancing Mammary Differentiation by Overcoming Lineage Specific Epigenetic Modification and Signature Gene Expression of Fibroblast Derived iPSCs

Project description:Recent studies showed that Induced pluripotent stem cells (iPSCs) could hold memory of their origin and exhibit skewed differentiation potential. This finding reveals a severe limit for the application of iPSCs in cell-based therapy in case certain cell types are not available for reprograming from patients. Here we show that under a typical condition for mammary differentiation, iPSCs derived from mouse mammary epithelium cells (ME-iPSCs) exhibit mammary signature gene expression and chromatin epigenetic modification, leading to smooth progress for mammary gland formation. In contrast, iPSCs reprogramed from tail fibroblasts (TF-iPSCs) displayed fibroblast specific signature that is not compatible for mammary differentiation both in vitro and in vivo. Strikingly, when co-culturing with ME-iPSCs or under pregnant condition, the fibroblast specific signature of TF-iPSCs was erased and the cells gained enhanced ability for mammary differentiation. These findings provide new insights into the precise control of differentiation conditions for future personalized cell-based therapy. Microarray analysis of three cell types with three biological replications.

2015-05-28 | E-GEOD-38471 | biostudies-arrayexpress

Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis II

Project description:To examine whether commonly used human cultured fibroblast systems model human cardiac fibroblasts, we tested three different fibroblast cell preparations: primary human cardiac fibroblasts (NHCF), human dermal fibroblasts (NHDF), and immortalized human cardiac fibroblasts (iHCF).

2024-07-01 | GSE218391 | GEO

A cardiac fibroblast-enriched micropeptide regulates inflammation

Project description:A cardiac fibroblast-enriched micropeptide regulates inflammation

| PRJNA1105958 | ENA

Enhancing Mammary Differentiation by Overcoming Lineage Specific Epigenetic Modification and Signature Gene Expression of Fibroblast Derived iPSCs

2015-05-28 | GSE38471 | GEO